Cardinal Health, Inc. (CAH)

Cardinal Health Stock Forecast

Stock Price Forecast

According to 15 professional analysts, the 12-month price target for Cardinal Health stock ranges from a low of $120 to a high of $203. The average analyst price target of $159 forecasts a 7.35% increase in the stock price over the next year.

Price Target: $159.00 (+7.35%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$120	$159	$150	$203
Change	-18.98%	+7.35%	+1.27%	+37.05%

Analyst Ratings

The average analyst rating for Cardinal Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	5	5	5	5	5	4
Buy	5	5	5	6	6	7
Hold	5	5	5	4	4	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	15	15	15	15	15	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Stephen Baxter Wells Fargo	Wells Fargo	Buy Maintains $183 → $185	Buy	Maintains	$183 → $185	+24.90%	Aug 13, 2025
Elizabeth Anderson Evercore ISI Group	Evercore ISI Group	Buy Maintains $200 → $190	Buy	Maintains	$200 → $190	+28.27%	Aug 13, 2025
Eric Coldwell Baird	Baird	Buy Maintains $197 → $203	Buy	Maintains	$197 → $203	+37.05%	Aug 13, 2025
Michael Cherny Leerink Partners	Leerink Partners	Buy Maintains $188 → $186	Buy	Maintains	$188 → $186	+25.57%	Aug 12, 2025
Erin Wright Morgan Stanley	Morgan Stanley	Buy Maintains $181 → $190	Buy	Maintains	$181 → $190	+28.27%	Jul 16, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

251.75B

Increased by 13.11%

from 222.58B

Revenue Next Year

270.86B

Increased by 7.59%

from 251.75B

EPS This Year

9.33

Increased by 44.61%

from 6.45

EPS Next Year

10.56

Increased by 13.19%

from 9.33

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026	Jun 30, 2027	Jun 30, 2028
Revenue	162.47B	181.33B	204.98B	226.83B	222.58B	251.75B	270.86B	291.00B
Revenue Growth	6.24%	11.61%	13.04%	10.66%	-1.87%	13.11%	7.59%	7.43%
EPS	2.08	-3.37	1.26	3.45	6.45	9.33	10.56	11.80
EPS Growth	-	-	-	173.81%	86.96%	44.61%	13.19%	11.74%
Forward PE	-	-	-	-	-	15.88	14.03	12.56
No. Analysts	-	-	-	-	-	20	14	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029
High	264.0B	286.3B	311.8B
Avg	251.8B	270.9B	291.0B
Low	237.1B	255.5B	275.4B

Revenue Growth

Revenue Growth	2026	2027	2028	2029
High	18.6%	13.7%	15.1%
Avg	13.1%	7.6%	7.4%
Low	6.5%	1.5%	1.7%

EPS Forecast

EPS	2026	2027	2028	2029
High	9.77	11.10	12.52
Avg	9.33	10.56	11.80
Low	8.82	10.06	11.07

EPS Growth

EPS Growth	2026	2027	2028	2029
High	51.4%	19.0%	18.6%
Avg	44.6%	13.2%	11.7%
Low	36.7%	7.9%	4.9%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.